Cite
MLA Citation
J Carter et al.. “Use of Precision Medicine Molecular Profiling of Baseline Tumor Specimen May Not Benefit Outcomes in Children With Relapsed or Refractory Pediatric Sarcomas.” Clinical pharmacology & therapeutics, vol. 101, no. 3, 2017, pp. 328–330. http://access.bl.uk/ark:/81055/vdc_100041723304.0x000055